RFG Advisory Portfolio holdings
Top Buys
| 1 |
BioCryst Pharmaceuticals
BCRX
|
+$22.3M |
| 2 |
BDBT
Bluemonte Core Bond ETF
BDBT
|
+$19.8M |
| 3 |
Ondas Inc
ONDS
|
+$19.3M |
| 4 |
BLUX
Bluemonte Dynamic Total Market ETF
BLUX
|
+$17.1M |
| 5 |
BLUC
Bluemonte Large Cap Core ETF
BLUC
|
+$12.5M |
Top Sells
| 1 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$19.5M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$16M |
| 3 |
SP Funds Dow Jones Global Sukuk ETF
SPSK
|
+$15.7M |
| 4 |
Dimensional International High Profitability ETF
DIHP
|
+$14.3M |
| 5 |
WisdomTree US LargeCap Dividend Fund
DLN
|
+$10.2M |
Sector Composition
| 1 | Technology | 4.5% |
| 2 | Consumer Discretionary | 1.87% |
| 3 | Healthcare | 1.72% |
| 4 | Financials | 1.58% |
| 5 | Communication Services | 1.48% |
Similar funds
RFG Advisory's Q1 2026 Portfolio in Review
As of Q1 2026, RFG Advisory held 1,131 positions worth $5.44B, up 2.5% from $5.31B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
RFG Advisory deployed $221M of net new capital in Q1 2026, opening 152 new positions and adding to 498 existing holdings. Its largest new stake was BioCryst Pharmaceuticals: 2,870,700 shares worth $27.3M.
By sector, the portfolio is most concentrated in Technology at 4.5% of assets, down from 4.9% a quarter earlier, followed by Consumer Discretionary and Healthcare.
On the sell side, the largest reduction was iShares 7-10 Year Treasury Bond ETF, an estimated $19.5M trimmed.
- RFG Advisory's largest Q1 2026 buy was BioCryst Pharmaceuticals: 2,870,700 shares worth $27.3M.
- RFG Advisory added most to Bluemonte Core Bond ETF in Q1 2026, an estimated $19.8M increase.
- RFG Advisory's biggest Q1 2026 reduction was iShares 7-10 Year Treasury Bond ETF, cutting an estimated $19.5M.
- RFG Advisory fully exited American Century US Quality Growth ETF in Q1 2026, selling an estimated $8.01M.
- RFG Advisory's ten largest holdings make up 41% of its $5.44B portfolio in Q1 2026.
- RFG Advisory opened 152 new positions and closed 94 in Q1 2026.
- RFG Advisory's portfolio value rose 2.5% quarter-over-quarter to $5.44B.
Based on RFG Advisory's 13F filing for Q1 2026, filed 20 Apr 2026.